Baliga RS - Search Results

1

Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, Xiao F, Gane PJ, Rebstock AS, Worthington RJ, Simone MI, Mota F, Rivilla F, Vallejo S, Peiró C, Sánchez Ferrer CF, Djordjevic S, Caulfield MJ, MacAllister RJ, Selwood DL, Ahluwalia A, Hobbs AJ. Moyes AJ, et al. Among authors: baliga rs. J Clin Invest. 2014 Sep;124(9):4039-51. doi: 10.1172/JCI74281. Epub 2014 Aug 8. J Clin Invest. 2014. PMID: 25105365 Free PMC article.

2

C-type natriuretic peptide co-ordinates cardiac structure and function.

Moyes AJ, Chu SM, Aubdool AA, Dukinfield MS, Margulies KB, Bedi KC, Hodivala-Dilke K, Baliga RS, Hobbs AJ. Moyes AJ, et al. Among authors: baliga rs. Eur Heart J. 2020 Mar 1;41(9):1006-1020. doi: 10.1093/eurheartj/ehz093. Eur Heart J. 2020. PMID: 30903134 Free PMC article.

3

Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-A.

Panayiotou CM, Baliga R, Stidwill R, Taylor V, Singer M, Hobbs AJ. Panayiotou CM, et al. Br J Pharmacol. 2010 Aug;160(8):2045-54. doi: 10.1111/j.1476-5381.2010.00830.x. Br J Pharmacol. 2010. PMID: 20649600 Free PMC article.

4

Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase.

Baliga RS, Milsom AB, Ghosh SM, Trinder SL, Macallister RJ, Ahluwalia A, Hobbs AJ. Baliga RS, et al. Circulation. 2012 Jun 12;125(23):2922-32. doi: 10.1161/CIRCULATIONAHA.112.100586. Epub 2012 May 9. Circulation. 2012. PMID: 22572914 Free PMC article.

5

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Baliga RS, Scotton CJ, Trinder SL, Chambers RC, MacAllister RJ, Hobbs AJ. Baliga RS, et al. Br J Pharmacol. 2014 Jul;171(14):3463-75. doi: 10.1111/bph.12694. Br J Pharmacol. 2014. PMID: 24641440 Free PMC article.

6

Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.

Baliga RS, Zhao L, Madhani M, Lopez-Torondel B, Visintin C, Selwood D, Wilkins MR, MacAllister RJ, Hobbs AJ. Baliga RS, et al. Am J Respir Crit Care Med. 2008 Oct 15;178(8):861-9. doi: 10.1164/rccm.200801-121OC. Epub 2008 Aug 8. Am J Respir Crit Care Med. 2008. PMID: 18689467 Free PMC article.

7

Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application.

Baliga RS, Macallister RJ, Hobbs AJ. Baliga RS, et al. Handb Exp Pharmacol. 2013;218:477-511. doi: 10.1007/978-3-642-38664-0_19. Handb Exp Pharmacol. 2013. PMID: 24092352 Review.

8

Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.

Bubb KJ, Trinder SL, Baliga RS, Patel J, Clapp LH, MacAllister RJ, Hobbs AJ. Bubb KJ, et al. Among authors: baliga rs. Circulation. 2014 Aug 5;130(6):496-507. doi: 10.1161/CIRCULATIONAHA.114.009751. Epub 2014 Jun 4. Circulation. 2014. PMID: 24899690 Free PMC article.

9

Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure.

Preedy MEJ, Baliga RS, Hobbs AJ. Preedy MEJ, et al. Among authors: baliga rs. J Cardiovasc Pharmacol. 2020 May;75(5):370-384. doi: 10.1097/FJC.0000000000000724. J Cardiovasc Pharmacol. 2020. PMID: 31498237 Review.

10

New perspectives for the treatment of pulmonary hypertension.

Baliga RS, MacAllister RJ, Hobbs AJ. Baliga RS, et al. Br J Pharmacol. 2011 May;163(1):125-40. doi: 10.1111/j.1476-5381.2010.01164.x. Br J Pharmacol. 2011. PMID: 21175577 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters